Updated Jul 16, 2026
Jones Mitchell Lawrence has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $110K.
Mitchell Lawrence Jones is the Chief Medical Officer at Palisade Bio, Inc., a clinical-stage biopharmaceutical company focused on developing therapeutics for intestinal barrier protection. He has been involved in the company's efforts to advance its product portfolio, including treatments for inflammatory bowel disease.
| Role | Chief Medical Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-08 | PALI | PALISADE BIO, INC. | S — Open-market sale | 51.9K | $2.05 | $107K |
| 2026-07-08 | PALI | PALISADE BIO, INC. | M — Option exercise | 131.2K | — | |
| 2026-02-14 | PALI | PALISADE BIO, INC. | S — Open-market sale | 2.0K | $1.75 | $3K |
| 2026-02-14 | PALI | PALISADE BIO, INC. | M — Option exercise | 8.0K | — |
Mitchell Lawrence Jones is the Chief Medical Officer at Palisade Bio, Inc., a clinical-stage biopharmaceutical company focused on developing therapeutics for intestinal barrier protection. He has been involved in the company's efforts to advance its product portfolio, including treatments for inflammatory bowel disease.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($110K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Jones Mitchell Lawrence profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.